Medicines update

Di-Gesic/Doloxene questions answered  

The TGA has produced a set of Q&As for consumers, pharmacists and doctors to resolve confusion regarding the new Prescriber Confirmation Form, required for users of products containing dextropropoxyphene.

The TGA decided last year that a series of new conditions were required for the registration and supply of dextropropoxyphene-containing pain-killers Di-Gesic and Doloxene.